Leadership Overview
Baxter has 4 executives leading key functions including finance, regional operations, product development, and communications.
Driven by a commitment to patient care, Baxter develops and manufactures essential medical devices, pharmaceuticals, and hospital care products, impacting healthcare providers globally.
Driven by a commitment to patient care, Baxter develops and manufactures essential medical devices, pharmaceuticals, and hospital care products, impacting healthcare providers globally.
Leadership Roles at Baxter
Anita Zielinski - Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer & Controller
Anita Zielinski, the Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer & Controller at Baxter, directs financial operations and accounting integrity. Overseeing the controller functions, Zielinski ensures accurate financial reporting and compliance across all global operations. This leadership position involves managing the company's fiscal health, including budgeting, forecasting, and capital allocation, directly supporting Baxter's mission to advance healthcare. By maintaining robust internal controls and driving financial efficiency, Anita Zielinski safeguards the company's assets and supports strategic growth initiatives. The controller's oversight extends to all financial transactions, ensuring adherence to regulatory standards and best practices in financial management. Zielinski's role is critical in providing transparent financial insights to stakeholders and guiding the company's financial strategy.
Andrew Frye - Senior Vice President & President (APAC)
Andrew Frye, the Senior Vice President & President (APAC) at Baxter, spearheads regional operations across the Asia-Pacific market. Frye drives business strategy and execution within this vital geographic segment, focusing on expanding Baxter's reach and impact. Overseeing all commercial activities in the APAC region, the Senior Vice President & President (APAC) ensures alignment with global objectives while adapting to local market dynamics. This leadership role involves managing diverse teams and product portfolios, including infusion systems and pharmaceuticals, to meet the healthcare needs of the region. By fostering strong relationships with healthcare providers and stakeholders, Andrew Frye enhances Baxter's market presence and contributes to improved patient outcomes. The strategic direction set by Frye is crucial for sustained growth and operational excellence throughout the APAC territories.
Cecilia Soriano - Group President, Infusion Therapies Technologies & Pharmaceuticals
Cecilia Soriano, the Group President, Infusion Therapies Technologies & Pharmaceuticals at Baxter, directs the strategic development and commercialization of key product lines. Soriano oversees the innovation pipeline for infusion systems, advanced medical technologies, and pharmaceutical offerings, ensuring they meet evolving healthcare demands. This critical role involves guiding research and development efforts, manufacturing processes, and market strategies for these essential Baxter products. By fostering cross-functional collaboration, Cecilia Soriano drives the integration of technologies and therapies to deliver comprehensive patient care solutions. The Group President, Infusion Therapies Technologies & Pharmaceuticals ensures that Baxter's portfolio remains at the forefront of medical advancement, supporting hospitals and clinics worldwide. Soriano's leadership is pivotal in expanding access to life-sustaining treatments and enhancing operational efficiency across these vital business segments.
Stacey Eisen - Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation
Stacey Eisen, the Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation at Baxter, shapes the company's global brand narrative and stakeholder engagement. Eisen directs all internal and external communications strategies, ensuring consistent messaging across diverse platforms and audiences. Overseeing corporate marketing initiatives, the Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation drives brand visibility and market positioning for Baxter's extensive range of medical devices and pharmaceuticals. Furthermore, Eisen leads the Baxter Foundation, advancing philanthropic efforts and community impact. By cultivating strong relationships with media, employees, and the public, Stacey Eisen reinforces Baxter's commitment to healthcare innovation and corporate responsibility. This multifaceted role is essential for maintaining Baxter's reputation and fostering trust among its global partners.
Explore Leadership Teams in Manufacturing
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership BG
NP
NC
Founded in 1969, Themis Medicar is a pharmaceutical company that specializes in manufacturing pharmaceuticals and medicinal chemicals for cardiology, pain management, anti-infectives, haematinics, and health and nutrition. Themis Medicare is located in India.
Company Leadership HM
TD
MS
RP
Gufic Group is a respected player in the pharmaceutical industry, established in 1970, known for its innovative and high-quality pharmaceutical and herbal products, along with a diverse range of APIs. They are recognized as one of India's largest manufacturers of lyophilized injections, offering a variety of products including antibiotics, antifungals, and antiviral treatments. Their extensive network facilitates the supply of these products to major hospital chains and leading medical facilities across India. Gufic is committed to research and development, continuously launching advanced new products while expanding their international footprint.
Company Leadership NY
SD
DR
Santa Farma is a prominent pharmaceutical company in Turkey, leading the healthcare sector since 1944 with a wide range of medications produced using modern manufacturing techniques. The company has built a strong reputation and trust in the industry through licensed production and multinational collaborations. Santa Farma is committed to values such as sensitivity to people, openness to development, rational strength, and respect for work, workplace, and society. Their products and services are primarily aimed at healthcare professionals.
Company Leadership SK
DA
TB
EA
Frequently Asked Questions Regarding Baxter Top Executives and Leadership Team
Unlock more people and company data
